The size of the Global Drug Screening Market has been estimated at USD 5.9 billion in 2019 and predicted to grow at a CAGR of 9.8% to reach USD 9.42 billion by 2024.
Drug screening tests utilize biological samples such as saliva, blood, and hair to detect the presence of drugs or drugs’ metabolites in a person at a certain point in time. The rapid advancements in science and technology are resulting in the invention of various new kinds of drug screening tests that provide better accuracy.
The factors which are significantly boosting the growth of the global drug screening market are increased prevalence of drug abuse and illegal applications of the drugs. Enforcement of stringent laws for drug and alcohol testing is contributing to the growth of drug screening market. The emergence of novel and innovative products into the market owing to regulatory approvals is another significant factor which is catalyzing the growth of platelet drug screening business. Increasing concerns over safety at the workplace have made the drug screening tests a mandatory at regular intervals. Increasing demand for non-invasive screening devices is boosting the growth of the drug screening market around the world.
The emergence of novel and useful drug testing practices at workplaces such as oral fluid and availability of technologically advanced pain management facilities and drug management facilities are expedited to offer lucrative growth opportunities for the key players operating in drug screening market during the forecast period. Increasing focus of the various governments across the world are enforcing stringent laws and increasing the funding to adopt advanced and effective screening devices to curb the illegal usage of un-prescripted drugs. Favourable regulatory conditions and easy approvals leading to escalation of R & D activities and rise in account of product launches are supposed to create more growth opportunities for the stakeholders in drug screening market.
The critical problem that is restraining the application of drug screening devices is the high costs of the equipment. Notably, the adoption of drug screening devices and testing practices are practised on a low rate in underdeveloped and developing countries due to budget limitations. Another factor that is challenging the growth of the drug screening market is breath analyzers are unreliable in a significant number of cases, and it has a history of providing inaccurate results. Consumption of drugs and alcohol are strictly prohibited and is very minimal in Islamic nations due to religious reasons, and this is another major factor which is resisting the growth of the global drug screening market.
Key happenings in this market in the recent past:
Market Size Available
2018 – 2024
2019 - 2024
By sample type, products & services, End-User, Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
Market Leaders Profiled
Thermo Fisher Scientific Inc., Express Diagnostics Int’l Inc., Abbott Laboratories, Siemens AG, Alere Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Biorad Laboratories Inc., Shimadzu and Omega Laboratories.
This market research report on Global Drug Screening Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.
Drug Screening Market Analysis - By Sample Type
On the basis of the sample type, the urine sample segment has occupied the leading shares in the market in 2019.
Drug Screening Market Analysis - By End-user
On the basis of end-user, the workplace segment is expected to grow at a high growth rate, owing to the increasing number of mandatory drug screening tests in the recruitment process of many companies.
Drug Screening Market Analysis - By Products & Services
On the basis of products & services, the Breathalyser segment is predicted to be the top contributor to the global market share.
North America provided the largest market for Drug Screening in 2019, because of the extremely stringent regulations enforced by regulatory agents like the Drug Enforcement Agency (DEA) of the United States in the region. Asia-Pacific region portrays a high growth rate for the recent future.
Leading market participants in the Global Drug Screening Market:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Sample Type
5.1.6 Y-o-Y Growth Analysis, By Sample Type
5.1.7 Market Attractiveness Analysis, By Sample Type
5.1.8 Market Share Analysis, By Sample Type
5.2.4 Criminal Justice & Law Enforcement
5.2.5 Y-o-Y Growth Analysis, By End-user
5.2.6 Market Attractiveness Analysis, By End-user
5.2.7 Market Share Analysis, By End-user
5.3 Products and Services
5.3.3 Rapid Test Device
5.3.4 Immunoassay Analyser
5.3.6 Other Products
5.3.7 Y-o-Y Growth Analysis, By Products and Services
5.3.8 Market Attractiveness Analysis, By Products and Services
5.3.9 Market Share Analysis, By Products and Services
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Sample Type
220.127.116.11 By End-user
18.104.22.168 By Application
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Sample Type
188.8.131.52 By End-user
184.108.40.206 By Products and Services
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Sample Type
22.214.171.124 By End-user
126.96.36.199 By Products and Services
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Express Diagnostics Int’l Inc.
8.3 Abbott Laboratories
8.4 Siemens AG
8.5 Alere Inc.
8.6 Quest Diagnostics Incorporated
8.7 Laboratory Corporation of America Holdings
8.8 Biorad Laboratories Inc.
8.10 Omega Laboratories
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures